Liebau Rowyn C, Waters Crystal, Ahmed Arooba, Soni Rajesh K, Gautier Jean
Institute for Cancer Genetics, Graduate School of Arts and Sciences, Columbia University, New York, NY, 10027, United States of America.
Institute of Cancer Genetics, Columbia University Irving Medical Center, New York, NY 10032, United States of America.
bioRxiv. 2024 Jan 6:2023.05.10.538304. doi: 10.1101/2023.05.10.538304.
DNA interstrand crosslinks (ICLs) are covalent bonds between bases on opposing strands of the DNA helix which prevent DNA melting and subsequent DNA replication or RNA transcription. Here, we show that Ultraviolet Stimulated Scaffold Protein A (UVSSA) participates in transcription-coupled repair of ICLs in human cells. Inactivation of UVSSA sensitizes human cells to ICL-inducing drugs, and delays ICL repair. UVSSA is required for transcription-coupled repair of a single ICL in a fluorescence-based reporter assay. UVSSA localizes to chromatin following ICL damage, and interacts with transcribing Pol II, CSA, CSB, and TFIIH. Specifically, UVSSA interaction with TFIIH is required for ICL repair. Finally, UVSSA expression positively correlates with ICL chemotherapy resistance in human cancer cell lines. Our data strongly suggest that transcription-coupled ICL repair (TC-ICR) is a ICL repair mechanism that contributes to crosslinker drug resistance independently of replication-coupled ICL repair.
DNA链间交联(ICLs)是DNA螺旋反向链上碱基之间的共价键,它会阻止DNA解链以及随后的DNA复制或RNA转录。在此,我们表明紫外线刺激支架蛋白A(UVSSA)参与人类细胞中ICLs的转录偶联修复。UVSSA失活会使人类细胞对ICL诱导药物敏感,并延迟ICL修复。在基于荧光的报告基因检测中,单个ICL的转录偶联修复需要UVSSA。ICL损伤后,UVSSA定位于染色质,并与正在转录的Pol II、CSA、CSB和TFIIH相互作用。具体而言,ICL修复需要UVSSA与TFIIH相互作用。最后,UVSSA的表达与人类癌细胞系中ICL化疗耐药性呈正相关。我们的数据有力地表明,转录偶联ICL修复(TC-ICR)是一种ICL修复机制,它独立于复制偶联ICL修复而导致交联剂耐药。